Detalhe da pesquisa
1.
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses.
Clin Infect Dis
; 75(1): e653-e661, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35079775
2.
90K, an interferon-stimulated gene product, reduces the infectivity of HIV-1.
Retrovirology
; 10: 111, 2013 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24156545
3.
The efficiency of Vpx-mediated SAMHD1 antagonism does not correlate with the potency of viral control in HIV-2-infected individuals.
Retrovirology
; 10: 27, 2013 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23497283
4.
Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants.
EBioMedicine
; 75: 103761, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34929493
5.
BNT162b2 booster after heterologous prime-boost vaccination induces potent neutralizing antibodies and T cell reactivity against SARS-CoV-2 Omicron BA.1 in young adults.
Front Immunol
; 13: 882918, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35958601
6.
An optimized MM/PBSA virtual screening approach applied to an HIV-1 gp41 fusion peptide inhibitor.
Proteins
; 79(11): 3221-35, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21989940